Daily oral 25-hydroxycholecalciferol supplementation for vitamin D deficiency in haemodialysis patients: effects on mineral metabolism and bone markers

Background. Vitamin D deficiency is frequently observed in end-stage renal disease (ESRD) patients; however, the effects of vitamin D supplementation have rarely been reported. We aimed to assess the effects of daily 25(OH)D3 supplementation on mineral metabolism, bone markers and Kidney Disease Out...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Nephrology, dialysis, transplantation dialysis, transplantation, 2008-11, Vol.23 (11), p.3670-3676
Hauptverfasser:	Jean, Guillaume, Terrat, Jean-Claude, Vanel, Thierry, Hurot, Jean-Marc, Lorriaux, Christie, Mayor, Brice, Chazot, Charles
Format:	Artikel
Sprache:	eng
Schlagworte:	25-hydroxyvitamin D Administration, Oral Aged Aged, 80 and over Alkaline Phosphatase - metabolism Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Biological and medical sciences Biomarkers - metabolism Bone and Bones - metabolism Bone Density Conservation Agents - therapeutic use bone markers Calcifediol - administration & dosage Calcifediol - therapeutic use Calcium - blood Dietary Supplements Dose-Response Relationship, Drug Emergency and intensive care: renal failure. Dialysis management Female General and cellular metabolism. Vitamins haemodialysis Humans Hydroxycholecalciferols - therapeutic use Intensive care medicine Kidney Failure, Chronic - complications Kidney Failure, Chronic - therapy Male Medical sciences Middle Aged mineral metabolism Outcome Assessment (Health Care) Pharmacology. Drug treatments Phosphorus - blood Renal Dialysis Vitamin D - administration & dosage Vitamin D - therapeutic use vitamin D deficiency Vitamin D Deficiency - drug therapy Vitamin D Deficiency - metabolism
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!